Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-079882
Filing Date
2025-08-18
Accepted
2025-08-18 17:16:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2523368d2_424b5.htm 424B5 6924
2 GRAPHIC tm2523368d2_424b5img001.jpg GRAPHIC 19439
  Complete submission text file 0001104659-25-079882.txt   34857
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275261 | Film No.: 251228846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)